Costing Dengue Fever Cases and Outbreaks: Recommendations from a Costing Dengue Working Group in the Americas

Value in Health Regional Issues

Volumn 8, Issue , 2015, Pages 80-91

  Constenla, Dagna ^a,b   Armien, Blas ^c   Arredondo, Juan ^d   Carabali, Maribel ^b   Carrasquilla, Gabriel ^e   Castro, Raul ^f   Durand, Laure ^g   Durán Arenas, Luis ^h   García, Maria Elena ⁱ   Gallegos, Rivera Verónica ^j   Gontes, Maria Luisa ^k   López, Juan Guillermo ^l   McFarlane, Charlton ^m   Montoya, Romeo ⁿ   Sartori, Ana Maria ^o   Siqueira, João Bosco ^p   Martelli, Celina Turchi ^p,q  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b International Vaccines Institute Dengue Vaccine Initiative (DVI)   (South Korea)

^c GORGAS MEMORIAL INSTITUTE FOR HEALTH STUDIES   (Panama)

^d Secretary of Environment   (Mexico)

^e Center of Studies and Research in Health   (Colombia)

^f UNIVERSIDAD DE LOS ANDES   (Colombia)

^g SANOFI PASTEUR   (France)

^h UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

ⁱ Health Services Management   (Mexico)

^j Ministry of Health   (Mexico)

^k INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^l Ministry of Health ^*

^m Ministry of Health   (Jamaica)

ⁿ Pan American Health Organization   (El Salvador)

^o UNIVERSITY OF SÃO PAULO   (Brazil)

^p FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^q FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

more..

Author keywords

Costing; Dengue fever cases; Dengue outbreaks

Indexed keywords

ACCESS TO INFORMATION; ACCURACY; ARTICLE; COST BENEFIT ANALYSIS; COST OF ILLNESS; DENGUE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SURVEILLANCE; EPIDEMIC; HUMAN; MORTALITY; NONHUMAN; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; SOCIAL STATUS; VIRUS TRANSMISSION; WESTERN HEMISPHERE;

EID: 84938080024     PISSN: 22121099     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vhri.2015.06.001     Document Type: Article

References (29)

1. Bhatt S., Gething P.W., Brady O.J., et al. The global distribution and burden of dengue. Nature 2013, 496:504-507.
2. Constenla D, Garcia C, Lefcourt N, on behalf of the Dengue Costing Working Group. Assessing the economics of dengue: results from a systematic review of the literature. PharmacoEconomics J. 2015. http://dx.doi.org/10.1007/s40273-015-0294-7.
3. Constenla D., Lefcourt N., Garcia C. Expert consensus building in developing guidelines: lessons learned form a dengue economics workshop in the Americas. Pan Am J Public Health 2013, 34:198-203.
4. Shepard D.S., Hodgkin D., Anthony Y.E. World Health Organization. Analysis of Hospital Costs. A Manual for Managers 2000, World Health Organization, Geneva.
5. Mills A. The economics of hospitals in developing countries, part 1: expenditure patterns. Health Policy Plan 1990, 5:107-117.
6. Drummond M.F., Drummond M.F.M. for the Economic Evaluation of Health Care Programmes. Methods for the Economic Evaluation 2005, Oxford University Press, Oxford.
7. Edejer TT-T. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis 2003, World Health Organization, Geneva.
8. National Institute for Health and Care Excellence. Guide to the methods of technology appraisal 2013. 2013. Available from: . [Accessed May 16, 2014]. http://publications.nice.org.uk/guide-to-the-methods-of-technology-appraisal-2013.pmg9.
9. Haute Autorité de Santé. Choices in methods for economic evaluation. Available from: . [Accessed May 16, 2014]. http://www.has-sante.fr/portai/upload/docs/application/pdf/2012-10/choices_in_methods_for_economic_evaluation.pdf.
10. Ministério da Saúde. Diretrizes metodológicas: Estudos de avaliação econômica de tecnologias em saúde. Serie A. Normas e Manuais Tecnicos. Brasilia - DF, 2009. Available from: [Accessed April 15, 2013]. http://bvsms.saude.gov.br/bvs/publicacoes/avaliacao_economica_tecnologias_saude_2009.pdf.
11. Ministerio de la Proteccion Social - Republica de Colombia. Guía Metodológica para la elaboración de guías de atención integral en el sistema general de seguridad social en salud colombiana. 2010. Available from: [Accessed April 15, 2013]. http://https://www.minsalud.gov.co/.
12. Consejo de Salubridad General. Guía de evaluación de insumos para la salud. Mexico, 2011. Available from: [Accessed April 15, 2013]. http://www.csg.gob.mx/descargas/pdfs/cuadro_basico/guia_eval_insumos11052011.pdf.
13. Constenla D, Lefcourt N, Garcia C, on behalf of the expert panel. Proceedings of the workshop on developing regional guidelines for the estimation of costs of dengue with a focus on the Latin America and Caribbean region. Available from: . [Accessed April 15, 2014]. http://www.jhsph.edu/research/centers-and-institutes/ivac/.
14. Dengue Hemorrhagic Fever: Diagnosis, Treatment, Prevention and Control 1997, World Health Organization, World Health Organization, Geneva, Switzerland. 2nd ed.
15. World Health Organization. Dengue: Guidelines for diagnosis, treatment, prevention and control. 2009. Available from: . [Accessed April 15, 2014]. http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf?ua=1.
16. Halstead S.B. Dengue in the Americas and Southeast Asia: do they differ?. Rev Panam Salud Publica 2006, 20:407-415.
17. San Martín J.L., Brathwaite O., Zambrano B., et al. The epidemiology of dengue in the Americas over the last three decades: a worrisome reality. Am J Trop Med Hyg 2010, 82:128-135.
18. Special programme for research and training in tropical diseases. In: WHO/TDR. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control (WHO Library Cataloguing-in-Publication Data ed.) 2009, World Health Organization, World Health Organization, Geneva.
19. Seet R.C.S., Quek A.M.L., Lim E.C.H. Post-infectious fatigue syndrome in dengue infection. J Clin Virol 2007, 38:1-6.
20. González D., Martinez R., Castro O., et al. Evaluation of some clinical, humoral and imagenological parameters in patients of dengue haemorrhagic fever six months after acute illness. Dengue Bull 2005, 29:79.
21. García G., González N., Pérez A.B., et al. Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorders. Int J Infect Dis 2011, 15:e38-e43.
22. Whitehorn J., Farrar J. Dengue. Br Med Bull 2010, 95:161-173.
23. Barniol J., Gaczkowski R., Barbato E.V., et al. Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries. BMC Infect Dis 2011, 11:106.
24. Rigau-Perez J.G. Severe dengue: the new for new case definitions. Lancet Infect Dis 2006, 6:297-302.
25. World Health Organization. Dengue and dengue haemorrhagic fever. Fact sheet 117, 2009. Available from: . [Accessed May 16, 2014]. http://www.who.int/mediacentre/factsheets/fs117/en/.
26. Pan-American Health Organization. About the PCPCD dengue regional strategy. Available from: . [Accessed May 15, 2014]. http://www.paho.org/hq/index.php?option=com_content&view=category&layout=blog&id=1788&Itemid=1886.
27. The International Research Consortium on Dengue Risk Assessment, Management and Surveillance (IDAMS). Available from: . [Accessed May 15, 2014]. http://www.idams.eu/.
28. Bärnighausen T., Bloom D.E., Canning D., et al. Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus type b vaccine. Vaccine 2011, 29:2371-2380.
29. Bärnighausen T., Bloom D.E., Cafiero E.T., O'Brien J.C. Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus. Clin Microb Infect 2012, 18(Suppl. 5):70-76.